Development and Evaluation of Dissolving Microarray Patches for Co-administered and Repeated Intradermal Delivery of Long-acting Rilpivirine and Cabotegravir Nanosuspensions for Paediatric HIV Antiretroviral Therapy.

MLA

Moffatt, Kurtis, et al. “Development and Evaluation of Dissolving Microarray Patches for Co-Administered and Repeated Intradermal Delivery of Long-Acting Rilpivirine and Cabotegravir Nanosuspensions for Paediatric HIV Antiretroviral Therapy.” Pharmaceutical Research, vol. 40, no. 7, July 2023, pp. 1673–96. EBSCOhost, https://doi.org/10.1007/s11095-022-03408-6.

APA

Moffatt, K., Tekko, I. A., Vora, L., Volpe-Zanutto, F., Hutton, A. R. J., Mistilis, J., Jarrahian, C., Akhavein, N., Weber, A. D., McCarthy, H. O., & Donnelly, R. F. (2023). Development and Evaluation of Dissolving Microarray Patches for Co-administered and Repeated Intradermal Delivery of Long-acting Rilpivirine and Cabotegravir Nanosuspensions for Paediatric HIV Antiretroviral Therapy. Pharmaceutical Research, 40(7), 1673–1696. https://doi.org/10.1007/s11095-022-03408-6

Chicago

Moffatt, Kurtis, Ismaiel A. Tekko, Lalitkumar Vora, Fabiana Volpe-Zanutto, Aaron R. J. Hutton, Jessica Mistilis, Courtney Jarrahian, et al. 2023. “Development and Evaluation of Dissolving Microarray Patches for Co-Administered and Repeated Intradermal Delivery of Long-Acting Rilpivirine and Cabotegravir Nanosuspensions for Paediatric HIV Antiretroviral Therapy.” Pharmaceutical Research 40 (7): 1673–96. doi:10.1007/s11095-022-03408-6.